ProMIS Neurosciences Inc. - Common Shares — Financial Statistics (NASDAQ:PMN) | MetaTrader

Open full chart

News

Will Health Benefits Weakness Drag Elevance's Q2 Earnings?

Wall Street Analysts See a 230.23% Upside in Promis Neurosciences (PMN): Can the Stock Really Move This High?

All You Need to Know About Promis Neurosciences (PMN) Rating Upgrade to Buy

Wall Street Analysts Think Promis Neurosciences (PMN) Could Surge 231.78%: Read This Before Placing a Bet

Phoenix Mecano reports solid 2025 results with improving exit rates

ProMIS Neurosciences stock soars after $175 million private placement

ProMIS Neurosciences raises $175 million in PIPE financing

ProMIS Neurosciences completes enrollment for Alzheimer’s drug trial

ProMIS Neurosciences regains Nasdaq compliance with minimum bid price rule

ProMIS reports promising data for selective Alzheimer’s antibody

ProMIS Neurosciences stock rises after promising Alzheimer’s research data

ProMIS publishes study supporting plasma pTau as AD trial endpoint